Proteomic analysis in NSAIDs-treated primary cardiomyocytes

Journal of Proteomics

Volumn 73, Issue 4, 2010, Pages 721-732

  Baek, Seon Mi ^a   Ahn, Jin Sook ^a   Noh, Hae Sook ^a   Park, Jaeyong ^a   Kang, Sang Soo ^a   Kim, Deok Ryong ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Cardiomyocytes; NSAID; Proteomic analysis; Septin 8

Indexed keywords

CELECOXIB; DICLOFENAC; IBUPROFEN; MELOXICAM; NAPROXEN; ROFECOXIB; SCAFFOLD PROTEIN; SEPTIN; VALDECOXIB;

ARTICLE; CARDIOVASCULAR RISK; CELL CULTURE; HEART MUSCLE CELL; MEMBRANE STRUCTURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEOMICS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; CARDIOVASCULAR DISEASES; CELL SURVIVAL; CYTOSKELETAL PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOXICITY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GTP-BINDING PROTEINS; MUSCLE PROTEINS; MYOCYTES, CARDIAC; PROTEOMICS; RATS; RISK ASSESSMENT; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

EID: 74849088209     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2009.10.004     Document Type: Article

References (30)

1. Cashman J.N. The mechanism of action of NSAIDs in analgesia. Drugs 52 (1996) 13-23
2. Seibert K., and Masferrer J.L. Role of inducible cyclooxygenase (COX-2) in inflammation. Receptor 4 (1994) 17-23
3. Moore R.A., Derry S., and McQuary H.J. Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs:balancing gastrointestinal and cardiovascular risk. BMC Musculoskelet Disord 8 (2007) 73-84
4. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., and Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A 91 (1994) 12013-12017
5. Ray W.A., MacDonald T.M., Solomon D.H., Graham D.J., and Avorn J. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease. Pharmacoepidemiol Drug Saf 12 (2003) 67-70
6. Fitzgerald G.A. Coxibs and cardiovascular disease. N Engl J Med 351 (2004) 1709-1711
7. Seibert K., Lefkowith J., Tripp C., Isakson P., and Needleman P. COX-2 inhibitors-is there cause for concern?. Nat Med 5 (1999) 621-622
8. Solomon S.D., McMurray J.J., Pfeffer M.A., Wittes J., Fowler R., Finn P., Anderson W.F., Zauber A., Hawk E., and Bertagnolli M. Cardiovascular risk associated with celecoxib in as clinical trial for colorectal adenoma prevention. New Eng J Med 352 (2005) 1071-1080
9. Solomon S.D. Cyclooxygenase-2 inhibitors and cardiovascular risk. Curr Opin Cardiol 21 (2006) 613-617
10. Grosser T., Fries S., and FitzGerald G.A. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 116 (2006) 4-15
11. Quann E.J., Kjwaja F., Zavitz K.H., and Djakiew D. The aryl propionic acid R-flurbiprofen selectively induces p75NTR dependent decreased survival of prostate tumor cells. Cancer Res 67 (2007) 3254-3262
12. Tanaka K., Tomisato W., Hoshino T., Ishihara T., Namba T., Aburaya M., Katsu T., Suzuki K., Tsutsumi S., and Mizushima T. Involvement of intracellular Ca2+ levels in non-steiroidal anti-inflammatory drug induced apoptosis. J Biol Chem 280 (2005) 31059-31067
13. Ng L.E., Halliwell B., and Wong K.P. Nephrotoxic cell death by diclofenac and meloxicam. Biochem Biophy Res Comm 369 (2008) 873-877
14. Fu J., Gao J., Pi R., and Liu P. An optimized protocol for culture of cardiomyocytes from neonatal rat. Cytotechnol 49 (2005) 109-116
15. Bock J.M., Menon S.G., Goswami P.C., Sinclair L.L., Bedford N.S., Domann F.E., and Trask D.K. Relative Non-steroid anti-inflammatory drug (NSAID) antiproliferative activity is mediated through p21-induced G1 arrest and E2F inhibition. Mol Carcinog 46 (2007) 857-864
16. Jin S.H., Cho E.H., Ko J.E., Jung E.H., Ahn B.C., Hahm J.R., Kim J.W., Kim C.W., and Kim D.R. Comparative analysis of nuclear proteins of B cells in different developmental stages. Proteomics 3 (2003) 2428-2436
17. Lou J., Fatima N., Xiao Z., Stauffer S., Smythers G., Greenwald P., and Ali I.U. Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells. Cancer Epidemiol Biomarkers Prev 15 (2006) 1598-1606
18. Suemasu S., Tanaka K.I., Namba T., Ishihara T., Katsu T., Fujimoto M., Adachi H., Sobue G., Takeuchi K., Nakai A., and Mizushima T. A role for HSP70 in protecting against indomethacin-induced gastric lesions. J Biol Chem 284 (2009) 19705-19715
19. Batulan Z., Nalbantoglu J., and Durham H.D. Nonsteroidal anti-inflammatory drugs differentially affect the heat shock response in cultured spinal cord cells. Cell Stress Chaperones 10 (2005) 185-196
20. Gehrmann M., Brunner M., Pfister K., Reichle A., Kremmer E., and Multhoff G. Differential up-regulation of cytosolic and membrane-bound heat shock protein 70 in tumor cells by anti-inflammatory drugs. Clin Cancer Res 10 (2004) 3354-3364
21. Mortaz E., Redegeld F.A., Bloksma N., Dunsmore K., Denenberg A., Wong H.R., Nijkamp F.P., and Engels F. Induction of HSP70 is dispensable for anti-inflammatory action of heat shock or NSAIDs in mast cells. Exp Hematol 34 (2006) 414-423
22. Takahashi S., Dohi N., Takahashi Y., and Miura T. Cloning and characterization of the 5′-flanking region of the rat P4Halpha gene encoding the prolyl 4-hydroxylase alpha(I) subunit. Biochim Biophys Acta 1574 (2002) 354-358
23. Willam C., Nicholls L.G., Ratcliffe P.J., Pugh C.W., and Maxwell P.H. The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor alpha. Adv Enzyme Regul 44 (2004) 75-92
24. Marxsen J.H., Stengel P., Doege K., Heikkinen P., Jokilehto T., Wagner T., Jelkmann W., Jaakkola P., and Metzen E. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J 381 (2004) 761-767
25. Fraisl P., Aragonés J., and Carmeliet P. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov 8 (2009) 139-152
26. Bläser S., Jersch K., Hainmann I., Wunderle D., Zgaga-Griesz A., Busse A., and Zieger B. Human septin-septin interaction: CDCrel-1 partners with KIAA0202. FEBS Lett 519 (2002) 169-172
27. McMurray M.A., and Thorner J. Reuse, replace, recycle. Specificity in subunit inheritance and assembly of higher-order septin structures during mitotic and meiotic division in budding yeast. Cell Cycle 8 (2009) 195-203
28. Silverman-Gavrila R.V., and Silverman-Gavrila L.B. Septins: new microtubule interacting partners. Sci World J 8 (2008) 611-620
29. Wloga D., Strzyzewska-Jówko I., Gaertig J., and Jerka-Dziadosz M. Septins stabilize mitochondria in Tetrahymena thermophila. Eukaryot Cell 7 (2008) 1373-1386
30. Hara A., Taguchi A., Niwa M., Aoki H., Yamada Y., Ito H., Nagata K., Kunisada T., and Mori H. Localization of septin 8 in murine retina, and spatiotemporal expression of septin 8 in a murine model of photoreceptor cell degeneration. Neurosci Lett 423 (2007) 205-210